Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome

Metabolism: Clinical and Experimental

Volumn 48, Issue 4, 1999, Pages 437-441

  Gonzalez, Frank ^a,b   Thusu, Kuldip ^a   Abdel Rahman, Ehad ^a   Prabhala, Anu ^a   Tomani, Madonna ^a   Dandona, Paresh ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANOVULATION; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032936968     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90100-2     Document Type: Article

References (22)

1. Franks S: Polycystic ovary syndrome. N Engl J Med 3.853-861, 1995
2. Dunaif A: Insulin resistance and ovarian dysfunction Endocrinologist 2:248-260, 1992
3. Burghen GA, Givens JR, Kitabchi AE: Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J Clin Endocrinol 50:113-116, 1980
4. Kolterman OG, Insel J, Saekow M, et al: Mechanisms of insulin resistance in human obesity. Evidence for receptor and post receptor defects. J Clin Invest 65:1272-1284, 1980
5. Ciarldi TP, Kolterman OG, Olefsky JM Mechanisms for the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity J Clin Invest 68:875-880, 1981
6. Old LJ: Tumor necrosis factor α: Structure, mechanisms of action, role of disease and therapy, in Bonavida B, Granger G (eds): Cytokines. New York, NY, Karger Basel, 1990, pp 1-30
7. Hotamisligil GS, Amer P, Caro JF, et al: Increased adipose tissue expression of tumor necrosis factor α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
8. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor α: Direct role in obesity-linked insulin resistance. Science 259 87-91, 1993
9. Hoffman C, Lorenz K, Braithwaite SS, et al: Altered gene expression for tumor necrosis factor α and its receptor during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
10. Dandona P, Weinstock R, Thusu K, et al: Tumor necrosis factor α in sera of obese patients: Fall with weight loss. J Clin Endocrinol 83:2907-2910, 1998
11. Stephens JM, Pekala PH: Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor α. J Biol Chem 266:21839-21845, 1991
12. Rosenbaum D, Haber RS, Dunaif A: Insulin resistance in polycystic ovary syndrome: Decreased expression of GLUT 4 glucose transporters in adipocytes. Am J Physiol 264:E197-E202, 1993
13. Dunaif A: Insulin resistance in polycystic ovary syndrome. Ann NY Acad Sci 687.60-64. 1993
14. Gonzalez F, Hatala DA, Speroff L: Adrenal and ovarian steroid hormone responses to gonadotropin releasing hormone agonist treatment in women with polycystic ovary syndrome. Am J Obstet Gynecol 195:535-545, 1991
15. Gonzalez F, Chang L, Horab T, et al: Evidence for heterogenous etiologies of adrenal dysfunction in polycystic ovary syndrome. Fertil Steril 66:354-361, 1996
16. Green PJ, Yucis MJ: Free testosterone determination by ultrafiltration and comparison with dialysis. Clin Chem 28:1237, 1982
17. Morales AJ, Laughlm GA, Butzow T, et al: Insulin, somatotropic and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features. J Clin Endocrinol Metab 81:2854-2864, 1996
18. Bergman RN, Beard JC, Chen M: The minimal modeling method. Assessment of insulin sensitivity and beta-cell function in vivo, in Clarke WL, Lamer J, Pohl SL (eds): Methods in Diabetes Research. New York, NY, Wiley, 1986, pp 15-34
19. Rebar RW: Gonadotropin secretion in polycystic ovary disease. Semin Reprod Endocrinol 2:223-230, 1984
20. DeVane GW, Czekula NM, Judd HL, et al: Circulatory gonadotropins, estrogens and androgens in polycystic ovarian disease. Am J Obstet Gynecol 121:496-500, 1975
21. Holte B, Leigh T, Gennarelli G, et al: The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women, Clin Endocrinol (Oxf) 41:473-481, 1994
22. Dale PO, Tanbo T, Vaaler S, et al: Body weight, hyperinsulinemia and gonadotropin levels in polycystic ovarian syndrome: Evidence of two distinct populations. Fertil Steril 58:487-491, 1992